Boschetti, Gilles <br/><br/>
Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.  [electronic resource] 

 -  Inflammatory bowel diseases  Jan 2011 
 - 160-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1536-4844 
<br/><br/><label>Standard No.: </label>10.1002/ibd.21308  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Crohn Disease--drug therapy<br/>Female<br/>Flow Cytometry<br/>Forkhead Transcription Factors--metabolism<br/>Humans<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Prospective Studies<br/>T-Lymphocytes, Regulatory--immunology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult